Protalix BioTherapeutics Inc.

ASE:PLX   4:00:00 PM EDT
1.64
+0.09 (+5.81%)
7:36:38 PM EDT: $1.64 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)130.77M
Current PE20.84
Forward PE 12.62
2yr Forward PE 2.98
See more stats
Estimates Current Quarter
Revenue$17.89 Million
Adjusted EPS$0.06
See more estimates
10-Day MA$1.59
50-Day MA$1.51
200-Day MA$1.97
See more pivots

Protalix BioTherapeutics Inc. Stock, ASE:PLX

2 University Plaza, Suite 100, Hackensack, New Jersey 07601
United States of America
Phone: +1.201.696.9345
Number of Employees: 213

Description

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.